Illinois General Assembly - Bill Status for HB4857

Synopsis As Introduced
Creates the Cancer Patient Choice Act. Provides that commercial insurance that covers specified radiation therapy for the delivery of a biological effective dose shall cover the delivery of the same biological effective dose for the same indication with physician-prescribed proton therapy and pay the same aggregate amount as an in-network service. Provides that the appropriate course of radiation therapy shall be determined and prescribed by the patient's treating radiation oncologist. Provides that the benefits required under the Act are subject to deductible and co-insurance amounts within the policy if the deductible and co-insurance are no greater than the deductible and co-insurance established for all other similar benefits within that policy. Provides that the Act does not apply to certain insurance coverage. Effective January 1, 2019.

Actions

Date	Chamber	Action
2/14/2018	House	Filed with the Clerk by Rep. Marcus C. Evans, Jr.
2/14/2018	House	First Reading
2/14/2018	House	Referred to Rules Committee
1/8/2019	House	Session Sine Die

×